Four antiangiogenesis drugs have been approved for human use in solid tumors but no validated biomarkers are available for routine clinical use. The roles and challenges of developing biomarkers of angiogenesis are reviewed. Nature Clinical Practice Oncology
This study aimed to assess the mast cell and microvessel densities in the invasive colorectal cancers and to determine their prognostic relevance for survival of the patient with colorectal carcinoma. Journal of Gastroenterology and Hepatology
In this Expert Interview, Dr. Charles D. Blanke discusses key clinical trials in colorectal cancer and identifies important factors that influence patient assessment and referral. Medscape Hematology-Oncology
Dr. Kathy Miller reports on a study that indicates routine cancer screening tests are overutilized in patients with advanced cancer and grossly underutilized in healthy patients over 65. Medscape Hematology-Oncology
